This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
DEPO-MEDROL
PFIZER CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DEPO-MEDROL in Canada?
Yes. DEPO-MEDROL 40MG has an active shortage reported to Health Canada (last updated July 10, 2026).
Why is DEPO-MEDROL not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will DEPO-MEDROL be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(40MG/ML WITH PRESERVATIVE)
SANDOZ CANADA INCORPORATED
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP
SANDOZ CANADA INCORPORATED
Other Products
DEPO-MEDROL
PFIZER CANADA ULC
METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE)
SANDOZ CANADA INCORPORATED
TARO-METHYLPREDNISOLONE INJECTION
TARO PHARMACEUTICALS INC
MEDROL TOPICAL 0.25%
PFIZER CANADA ULC
What this means
Does this mean my pharmacy is already out of stock?
No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.
What should I do?
No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.
Estimated Resolution
2026-10-30
~31 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
00030759
Strength
40MG
Dosage Form
SUSPENSION
Route
INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR
Active Ingredient
METHYLPREDNISOLONE ACETATE
Tier
Unrated
Last Updated
2026-09-16
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
DEPO-MEDROL has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347